{"id":11413,"date":"2011-06-08T00:00:00","date_gmt":"2011-06-07T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2011\/06\/08\/el-investigador-del-idibell-joan-gil-gana-el-premio-en-biomedicina-aplicada-valdes-salas\/"},"modified":"2020-05-26T11:52:36","modified_gmt":"2020-05-26T09:52:36","slug":"el-investigador-del-idibell-joan-gil-gana-el-premio-en-biomedicina-aplicada-valdes-salas","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2011\/06\/el-investigador-del-idibell-joan-gil-gana-el-premio-en-biomedicina-aplicada-valdes-salas\/","title":{"rendered":"El investigador del IDIBELL Joan Gil gana el Premio en Biomedicina Aplicada Vald\u00e9s-Salas"},"content":{"rendered":"<p><strong>El jefe del grupo de investigaci\u00f3n de apoptosis y c\u00e1ncer del IDIBELL, y catedr\u00e1tico de bioqu\u00edmica y biolog\u00eda molecular de la <a class=\"enllac\" href=\"http:\/\/www.ub.edu\/\" target=\"_blank\" rel=\"noopener noreferrer\">Universidad de Barcelona<\/a>, Joan Gil, ha sido galardonado con el I Premio en Biomedicina Aplicada de la <a href=\"http:\/\/www.fundacionvaldessalas.es\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"enllac\">Fundaci\u00f3n Vald\u00e9s-Salas<\/span><\/a>.  El jurado ha decidido por unanimidad conceder este galard\u00f3n a Joan Gil  por su labor investigadora en la b\u00fasqueda de nuevos tratamientos de  leucemias y linfomas de c\u00e9lulas B.<\/strong> <strong><br \/><\/strong> El trabajo experimental realizado por el grupo liderado por Joan Gil en colaboraci\u00f3n con la empresa <a href=\"http:\/\/www.advancell.net\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"enllac\">Advancell <\/span><\/a>ha permitido patentar el uso de la mol\u00e9cula Acadesina que ha superado con \u00e9xito todas las etapas de ensayos precl\u00ednicos y ha conducido finalmente al desarrollo de un ensayo cl\u00ednico, actualmente en curso, para el tratamiento de pacientes con leucemia linf\u00e1tica cr\u00f3nica. Este ensayo es el primero que se realiza para el tratamiento del c\u00e1ncer a partir de una patente generada por un grupo del sistema p\u00fablico espa\u00f1ol de investigaci\u00f3n. <b><br \/> El jurado ha destacado que el trabajo de Gil es un ejemplo de c\u00f3mo una investigaci\u00f3n b\u00e1sica de calidad, contrastada con publicaciones cient\u00edficas en revistas de notable prestigio, puede conducir a importantes aplicaciones pr\u00e1cticas en el \u00e1mbito de la medicina. <b><br \/> La Fundaci\u00f3n Vald\u00e9s-Salas convoca por primera vez este premio en colaboraci\u00f3n con la Universidad de Oviedo y las empresas Bayer, Cofas y Farmaindustria. El galard\u00f3n pretende reconocer la colaboraci\u00f3n exitosa entre investigadores y empresas. El objetivo es premiar investigaciones utilizadas por una empresa con resultados econ\u00f3micos positivos.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El jefe del grupo de investigaci\u00f3n de apoptosis y c\u00e1ncer del IDIBELL, y catedr\u00e1tico de bioqu\u00edmica y biolog\u00eda molecular de la Universidad de Barcelona, Joan Gil, ha sido galardonado con el I Premio en Biomedicina Aplicada de la Fundaci\u00f3n Vald\u00e9s-Salas.  El jurado ha decidido por unanimidad conceder este galard\u00f3n a Joan Gil  por su labor investigadora en la b\u00fasqueda de nuevos tratamientos de  leucemias y linfomas de c\u00e9lulas B.<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[246,184,281],"tags":[123],"class_list":["post-11413","post","type-post","status-publish","format-standard","hentry","category-apoptosis-y-cancer","category-area-cancer","category-programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell","tag-promocion"],"publishpress_future_action":{"enabled":false,"date":"2024-12-01 05:26:03","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=11413"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11413\/revisions"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=11413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=11413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=11413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}